January 15, 2004
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Literature review finds oxytetracycline effective for ocular rosacea
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Oxytetracycline may have a moderate treatment effect on ocular rosacea, according to a review of evidence-based literature the drug.
Donald Stone, MD and James Chodosh, MD, at the Dean A. McGee Eye Institute in Oklahoma City, Okla., reviewed the published literature and found two prospective, masked, placebo-controlled studies of oxytetracycline for the treatment of ocular rosacea. According to the studies, there is a moderate treatment benefit in ocular rosacea for oxytetracycline, a tetracycline derivative not currently available in the United States.
The review is published in the January issue of Cornea.